These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 21314823)

  • 1. Acute myeloid leukaemia in the elderly: a review.
    Pollyea DA; Kohrt HE; Medeiros BC
    Br J Haematol; 2011 Mar; 152(5):524-42. PubMed ID: 21314823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current and emerging therapies for acute myeloid leukemia.
    Robak T; Wierzbowska A
    Clin Ther; 2009; 31 Pt 2():2349-70. PubMed ID: 20110045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction and postremission strategies in acute myeloid leukemia: state of the art and future directions.
    Rosenblat TL; Jurcic JG
    Hematol Oncol Clin North Am; 2011 Dec; 25(6):1189-213. PubMed ID: 22093583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute myeloid leukemia in the elderly: conventional and novel treatment approaches.
    Craig CM; Schiller GJ
    Blood Rev; 2008 Jul; 22(4):221-34. PubMed ID: 18433953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remission induction, consolidation and novel agents in development for adults with acute myeloid leukaemia.
    Hamadani M; Awan FT
    Hematol Oncol; 2010 Mar; 28(1):3-12. PubMed ID: 19645073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia.
    Lekakis L; de Lima M
    Expert Rev Anticancer Ther; 2008 May; 8(5):785-98. PubMed ID: 18471050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Older patients with acute myeloid leukemia.
    Yee KW; Keating A
    Expert Rev Hematol; 2010 Dec; 3(6):755-74. PubMed ID: 21091151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging treatment strategies for acute myeloid leukemia (AML) in the elderly.
    Kuendgen A; Germing U
    Cancer Treat Rev; 2009 Apr; 35(2):97-120. PubMed ID: 18951721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment decision-making for older patients with high-risk myelodysplastic syndrome or acute myeloid leukemia: problems and approaches.
    Deschler B; de Witte T; Mertelsmann R; Lübbert M
    Haematologica; 2006 Nov; 91(11):1513-22. PubMed ID: 17082009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute myeloid leukemia in the elderly.
    Dombret H; Raffoux E; Gardin C
    Semin Oncol; 2008 Aug; 35(4):430-8. PubMed ID: 18692693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells.
    Lu C; Hassan HT
    Leuk Res; 2006 Mar; 30(3):296-302. PubMed ID: 16112192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of older patients with AML.
    Büchner T; Berdel WE; Wörmann B; Schoch C; Haferlach T; Schnittger S; Kern W; Aul C; Lengfelder E; Schumacher A; Reichle A; Staib P; Balleisen L; Eimermacher H; Grüneisen A; Rasche H; Sauerland MC; Heinecke A; Mesters RM; Serve HL; Kienast J; Hiddemann W
    Crit Rev Oncol Hematol; 2005 Nov; 56(2):247-59. PubMed ID: 16246568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Full-intensity and reduced-intensity allogeneic stem cell transplantation in AML.
    Craddock CF
    Bone Marrow Transplant; 2008 Mar; 41(5):415-23. PubMed ID: 18209726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative novel therapies for the treatment of elderly acute myeloid leukemia patients.
    Isidori A; Venditti A; Maurillo L; Buccisano F; Loscocco F; Manduzio P; Sparaventi G; Amadori S; Visani G
    Expert Rev Hematol; 2013 Dec; 6(6):767-84. PubMed ID: 24219553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute myeloid leukemia: a classification and treatment update.
    Iovino CS; Camacho LH
    Clin J Oncol Nurs; 2003; 7(5):535-40. PubMed ID: 14603550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel therapeutic agents in acute myeloid leukemia.
    Stone RM
    Exp Hematol; 2007 Apr; 35(4 Suppl 1):163-6. PubMed ID: 17379102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current and emerging strategies for the management of acute myeloid leukemia in the elderly.
    Laubach J; Rao AV
    Oncologist; 2008 Oct; 13(10):1097-108. PubMed ID: 18922830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical impact of nucleophosmin mutations and Flt3 internal tandem duplications in patients older than 60 yr with acute myeloid leukaemia.
    Scholl S; Theuer C; Scheble V; Kunert C; Heller A; Mügge LO; Fricke HJ; Höffken K; Wedding U
    Eur J Haematol; 2008 Mar; 80(3):208-15. PubMed ID: 18081718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myeloid leukemia in children: an evidence-based review.
    Oliansky DM; Rizzo JD; Aplan PD; Arceci RJ; Leone L; Ravindranath Y; Sanders JE; Smith FO; Wilmot F; McCarthy PL; Hahn T
    Biol Blood Marrow Transplant; 2007 Jan; 13(1):1-25. PubMed ID: 17222748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity in the therapeutic approach to relapsed elderly patients with acute myeloid leukaemia: a survey from the Gruppo Italiano Malattie Ematologiche dell' Adulto (GIMEMA) Acute Leukaemia Working Party.
    Ferrara F; Fazi P; Venditti A; Pagano L; Amadori S; Mandelli F
    Hematol Oncol; 2008 Jun; 26(2):104-7. PubMed ID: 18271064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.